Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) had Weighted-Average Shares Outstanding (Diluted) of 40.85M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-5.53M |
|
-- |
|
-- |
|
$6.08M |
|
$-6.08M |
|
$0.53M |
|
$-5.55M |
|
$-5.55M |
|
$-5.53M |
|
$-5.53M |
|
$-5.53M |
|
$-5.53M |
|
$-6.08M |
|
$-5.22M |
|
40.85M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
40.85M |
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$72.66M |
|
$3.27M |
|
$19.48M |
|
$92.14M |
|
$12.00M |
|
-- |
|
$13.66M |
|
$25.66M |
|
$66.48M |
|
$52.81M |
|
$66.48M |
|
40.85M |
|
| Cash Flow Statement Financials | |
$-3.37M |
|
$0.06M |
|
-- |
|
$71.85M |
|
$67.19M |
|
$-4.66M |
|
$0.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.32% |
|
-10.48% |
|
-6.01% |
|
-8.32% |
|
$1.63 |
|
$-0.08 |
|
$-0.08 |
|